Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 23,773 | 2,566 | -11,307 | -58,410 | -58,332 |
| Depreciation Amortization | 82 | 101 | 26 | 2,710 | 2,726 |
| Accounts receivable | -19 | -128 | -4 | 15 | -125 |
| Other Working Capital | 184 | -1,032 | -1,417 | 1,050 | 118 |
| Other Operating Activity | -33,392 | -8,252 | 9,011 | 47,195 | 50,709 |
| Operating Cash Flow | $-9,372 | $-6,745 | $-3,691 | $-7,440 | $-4,904 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,197 | -1,060 | -229 | -100 | -97 |
| Investing Cash Flow | $-1,197 | $-1,060 | $-229 | $-100 | $-97 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 18,887 | 2,000 |
| Debt Repayment | N/A | N/A | N/A | N/A | -26 |
| Other Financing Activity | 0 | 0 | 0 | 8,113 | 7,000 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $27,000 | $8,974 |
| Exchange Rate Effect | N/A | N/A | N/A | 40 | 24 |
| Beginning Cash Position | 20,355 | 20,355 | 20,355 | 860 | 862 |
| End Cash Position | 9,786 | 12,550 | 16,435 | 20,350 | 4,859 |
| Net Cash Flow | $-10,569 | $-7,805 | $-3,920 | $19,490 | $3,997 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,372 | -6,745 | -3,691 | -7,440 | -4,904 |
| Capital Expenditure | -1,197 | -1,060 | -229 | -102 | -97 |
| Free Cash Flow | -10,569 | -7,805 | -3,920 | -7,542 | -5,001 |